Big pharma, Biotech, Partnering, Pharma

Pfizer and Kyowa Hakko Kirin start a pharma alliance for immuno-oncology study

Posted on 01 October 2014

Tags: , , ,

Pfizer and Kyowa Hakko Kirin have entered into an pharma alliance agreement to explore the therapeutic potential of the combination of Pfizer’s PF-05082566 with Kyowa Hakko Kirin’s anti-CCR4 antibody mogamulizumab.

PF-05082566 is an investigational, fully humanized monoclonal antibody (mAb) that stimulates signaling through 4-1BB (CD-137).

Mogamulizumab which suppresses some of the immune cells that shield the tumor from the immune system, in a Phase Ib clinical study evaluating the safety and tolerability of the combination in patients with solid tumors.

Pfizer and Kyowa Hakko Kirin will co-fund the clinical study, which will be conducted by Pfizer.

This study is expected to establish a recommended dose regimen and assess the safety and preliminary efficacy of the combination.

This study is expected to begin in 2015 and the results will determine the future clinical development of the combination.

For further deal information visit Current Agreements (subscription required)

Related

Report: Partnering Deals and Alliances with Pfizer

Report: Pancreatic Cancer Partnering 2007-2012

Report: Partnering Deals and Alliances with Big Pharma  

Browse: Complete Current Partnering report catalog

View: Partnering Scorecard in CP Insight– view top life science partnering deals by value

View: DealMetrics in CP Insight – the latest deal trend infographics for life science deal making

View: CP Insight’s Big Pharma Deal Making Scorecard – latest trends in big pharma deal making activity

View: CP Insight’s Big Biotech Deal Making Scorecard – latest trends in big biotech deal making activity

Signup: Current Partnering Dealmakers Update – weekly newsletter providing the latest life science industry deal news, deal making trends, partnering events – sign up now

Signup: Current Agreements Deals Review – monthly newsletter – reviewing the previous month’s life science deal making – partnering, M&A and financing – sign up now

Subscribe: Current Agreements life sciences partnering, M&A and financing deals database – find out more

Follow us on: LinkedIn Current Partnering | LinkedIn Business Development Network | @Currentpartner on Twitter

Print Friendly, PDF & Email

Leave a Reply